Orphazyme A/S
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Orphazyme A/S generated cash of -$20,021, which is more than the previous year. Cash used in financing activities reached the amount of -$685 last year. Net change in cash is therefore -$27,649.
Cash Flow
| 2015 | -42.74K | -50 | 22.5K |
|---|---|---|---|
| 2016 | -54.72K | -238 | 1.3K |
| 2017 | -95.42K | -1.49K | 714.30K |
| 2018 | -234.76K | -2.34K | 0 |
| 2019 | -326.81K | -3.28K | 58.93K |
| 2020 | -539.07K | -5.10K | 1.15M |
| 2021 | -602.57K | 46 | -30.34K |
| 2022 | -117.94K | 90.34K | -35.07K |
| 2023 | -20.02K | -6.94K | -685 |
0CUM.L Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 38.91K | 102.25K | 726.92K | 123.58K | 394.70K | 631.73K | 14.34K | 78.16K | 0 |
Operating activities | |||||||||
Net income | -26.04K | 35.07K | -626.53K | -633.24K | -337.49K | -229.6K | -126.20K | -57.93K | -53.46K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 0 | 782 | 13.21K | 5.09K | 3.80K | 1.36K | 746 | 572 | 572 |
Stock-based compensation expense | 126 | 1.77K | 0 | 28.10K | 2.55K | 0 | 122 | 0 | 0 |
| Deferred income tax benefit | 126 | 1.77K | 0 | 28.10K | 2.55K | 0 | 122 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.87K | -526 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -20.02K | -117.94K | -602.57K | -539.07K | -326.81K | -234.76K | -95.42K | -54.72K | -42.74K |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -92 | -2.36K | -2.77K | -743 | -1.49K | -238 | -50 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -6.94K | 90.34K | 46 | -5.10K | -3.28K | -2.34K | -1.49K | -238 | -50 |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -3.02K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -40.38K | -29.16K | -13.50K | 58.92K | 0 | 0 | 0 | 14.92K |
Cash used in financing activities | -685 | -35.07K | -30.34K | 1.15M | 58.93K | 0 | 714.30K | 1.3K | 22.5K |
Net Change In Cash | -27.64K | -63.33K | -624.67K | 603.34K | -271.11K | -237.02K | 617.38K | -63.81K | 78.16K |
Cash at end of period | 11.26K | 38.91K | 102.25K | 726.92K | 123.58K | 394.70K | 631.73K | 14.34K | 78.16K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |